CagriSema Dosing Calculator
CagriSema: cagrilintide + semaglutide combination by Novo Nordisk.
Pre-filled with the most-reported community reconstitution protocol for CagriSema. See how 1 mL and 2 mL of bacteriostatic water change concentration and syringe-draw volume, then adjust the calculator below for your own vial.
Quick answer ยท Community-reported standard
A 10 mg vial of CagriSema reconstituted with 2 mL of bacteriostatic water yields a concentration of 5.00 mg/mL. At that concentration, a 2.4 mg dose of CagriSema equals 48 units on a U-100 insulin syringe (0.480 mL). CagriSema is typically administered once weekly via subcutaneous.
CagriSema reconstitution: 1 mL vs 2 mL bac water
Bacteriostatic water volume is flexible. Less water means higher concentration and smaller injection volumes; more water means lower concentration and easier dose precision. Both options below are valid for a 10 mg vial.
| BAC water added | Concentration | Volume per 2.4 mg dose | Draw on U-100 syringe (units) |
|---|---|---|---|
| 1 mL | 10.00 mg/mL | 0.240 mL | 24 units |
| 2 mL | 5.00 mg/mL | 0.480 mL | 48 units |
Calculate your CagriSema dose
Alternative CagriSema protocols
Beyond the default above, CagriSema is also reported in the following protocols. Use these as starting points and recalculate with the tool above.
Obesity / Weight Management (REDEFINE 1 trial protocol)
Clinical- Dose
- Once-weekly subcutaneous injection. Target maintenance dose is cagrilintide 2.4 mg plus semaglutide 2.4 mg. Gradual dose escalation over approximately 16-20 weeks to reach target maintenance dose.
- Frequency
- Once weekly subcutaneous injection
- Duration
- 68 weeks in Phase 3 trials; intended for long-term use
Co-administered as a single injection from a pre-filled pen. Dose escalation is required for both components to minimize GI side effects. Not yet FDA-approved.
Type 2 Diabetes with Obesity (REDEFINE 2 trial protocol)
Clinical- Dose
- Once-weekly subcutaneous injection. Target dose is cagrilintide 2.4 mg plus semaglutide 2.4 mg. Same dose escalation schedule as REDEFINE 1.
- Frequency
- Once weekly subcutaneous injection
- Duration
- 68 weeks in Phase 3 trial
Produced 13.7% weight loss and HbA1c reductions with 73.5% achieving HbA1c of 6.5% or less. Background diabetes medications may need dose adjustment.
CagriSema reconstitution & storage
CagriSema is supplied as a pre-filled pen device containing both cagrilintide and semaglutide in a single formulation. No reconstitution, mixing, or dilution is required.
Expected to follow semaglutide storage guidelines. Store refrigerated at 2-8 degrees C. Do not freeze. Specific storage conditions will be defined in prescribing information upon regulatory approval.
CagriSema dosing FAQ
How much bacteriostatic water should I add to a 10 mg vial of CagriSema?
The community standard is 2 mL of bacteriostatic water for a 10 mg CagriSema vial. That gives a concentration of 5.00 mg/mL, so a 2.4 mg dose is 48 units on a U-100 insulin syringe. Adding 1 mL instead doubles the concentration to 10.00 mg/mL and halves the draw to 24 units. Less water = smaller injection volume but harder to measure precisely.
How many syringe units is a 2.4 mg dose of CagriSema?
On a standard U-100 insulin syringe, a 2.4 mg dose of CagriSema is 48 units when the 10 mg vial is reconstituted with 2 mL of bacteriostatic water (5.00 mg/mL). If you use 1 mL of bac water instead, draw 24 units (10.00 mg/mL).
What is the standard CagriSema dose?
Community-reported protocols for CagriSema typically use 2.4 mg once weekly via Subcutaneous. 2.4 mg is a common starting dose. Community members attempt to replicate the clinical CagriSema combination by sourcing each component separately; carries significant dosing and quality risks
How long does a vial of CagriSema last at 2.4 mg once weekly?
A 10 mg vial of CagriSema contains roughly 4 doses at 2.4 mg per injection. At once weekly dosing, that is approximately 28 days (about 4 weeks) of supply per vial. Reconstituted CagriSema should generally be used within 28 days when refrigerated.
Where do you inject CagriSema?
CagriSema is typically injected subcutaneous. Common sites reported in the literature and by users include: Abdomen (at least 2 inches from navel), Front of thigh (middle third), Upper arm (back, upper outer area). Rotate sites with each injection to reduce localized irritation.
Can I use sterile water instead of bacteriostatic water for CagriSema?
Bacteriostatic water (containing 0.9% benzyl alcohol as a preservative) is strongly preferred for multi-dose vials like CagriSema because it inhibits microbial growth and lets a single vial be used over multiple weeks. Sterile water has no preservative and should generally be reserved for single-use preparations only.
More on CagriSema
CagriSema overview
Mechanism of action, primary uses, and research summary
CagriSema dosing protocols
Full clinical and research-based dosing reference
CagriSema community protocols
Real-world usage patterns from peptide communities
CagriSema side effects
Reported adverse effects and safety considerations
Compare CagriSema with
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.